| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3871310 | The Journal of Urology | 2009 | 6 Pages |
Abstract
Nephrectomy prolonged long-term overall survival in this updated analysis, supporting its role as standard therapy in patients with advanced renal cell carcinoma. A nephrectomy benefit was seen across all prespecified patient subsets. Early progressive disease and performance status were strong predictors of overall survival. These results support efforts to identify biomarkers of renal cell carcinoma resistance to treatment and early progressive disease to facilitate rational patient selection for systemic therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Primo N. Jr., Catherine M. Tangen, Sarah J. Conlon, Robert C. Flanigan, E. David Crawford,